Variables | Dill powder (n = 21) | Placebo (n = 21) | P valuea | P valueb | P valuec | P valued |
---|---|---|---|---|---|---|
FBS (mg/dl) | ||||||
 Baseline | 145.76 ± 50.81 | 148.61 ± 56.56 | 0.864 | 0.883 |  |  |
 End | 141.14 ± 40.37 | 154.23 ± 36.72 | 0.278 | 0.623 |  |  |
P valuee | 0.668 | 0.671 | Â | Â | Â | Â |
 Difference | −4.61 ± 48.56 | 5.61 ± 59.76 |  |  | 0.17 | 0.752 |
Insulin (μU/ml) | ||||||
 Baseline | 13.27 ± 3.8 | 11.61 ± 4.91 | 0.230 | 0.474 |  |  |
 End | 10.54 ± 4.51 | 12.12 ± 4.23 | 0.250 | 0.796 |  |  |
P valuee | 0.004* | 0.604 | Â | Â | Â | Â |
 Difference | −2.7 ± 3.83 | 0.50 ± 4.36 |  |  | 0.015* | 0.05 |
HOMA-IR | ||||||
 Baseline | 4.88 ± 2.37 | 4.37 ± 3.01 | 0.544 | 0.762 |  |  |
 End | 3.86 ± 2.32 | 4.60 ± 2.02 | 0.276 | 0.848 |  |  |
P valuee | 0.039* | 0.698 | Â | Â | Â | Â |
 Difference | −1.02 ± 2.12 | 0.23 ± 2.68 |  |  | 0.101 | 0.447 |
TG (mg/dl) | ||||||
 Baseline | 196.52 ± 60.16 | 194.66 ± 75.58 | 0.930 | 0.626 |  |  |
 End | 172.38 ± 69.86 | 190.19 ± 79.93 | 0.447 | 0.664 |  |  |
P valuee | 0.055 | 0.811 | Â | Â | Â | Â |
 Difference | −24.14 ± 54.29 | −4.47 ± 84.69 |  |  | 0.376 | 0.343 |
TC (mg/dl) | ||||||
 Baseline | 160.28 ± 38.26 | 154.42 ± 32.42 | 0.596 | 0.492 |  |  |
 End | 149.23 ± 26.7 | 156.8 ± 32.25 | 0.412 | 0.881 |  |  |
P valuee | 0.03* | 0.654 | Â | Â | Â | Â |
 Difference | −11.04 ± 21.7 | 2.38 ± 23.95 |  |  | 0.064 | 0.033* |
LDL-C (mg/dl) | ||||||
 Baseline | 81.00 ± 34.79 | 71.71 ± 23.55 | 0.318 | 0.516 |  |  |
 End | 71.23 ± 26.63 | 74.80 ± 22.80 | 0.643 | 0.357 |  |  |
P valuee | 0.029* | 0.325 | Â | Â | Â | Â |
 Difference | −9.76 ± 19.08 | 3.09 ± 14.07 |  |  | 0.017* | 0.04* |
HDL-C (mg/dl) | ||||||
 Baseline | 41.85 ± 11.68 | 43.14 ± 8.05 | 0.680 | 0.939 |  |  |
 End | 44.80 ± 9.89 | 41.76 ± 6.33 | 0.243 | 0.343 |  |  |
P valuee | 0.007* | 0.185 | Â | Â | Â | Â |
 Difference | 2.59 ± 4.51 | −1.38 ± 4.60 |  |  | 0.004* | 0.04* |